238
Participants
Start Date
September 30, 2011
Primary Completion Date
October 31, 2012
Study Completion Date
October 31, 2012
fluticasone furoate
Inhaled corticosteroid
albuterol/salbutamol
Provided as rescue relief of asthma symptoms
GSK Investigational Site, San Miguel de Tucumán
GSK Investigational Site, Utica
GSK Investigational Site, Bethesda
GSK Investigational Site, Orangeburg
GSK Investigational Site, Albany
GSK Investigational Site, Clearwater
GSK Investigational Site, Bourg-des-Comptes
GSK Investigational Site, Lexington
GSK Investigational Site, Toledo
GSK Investigational Site, Aigrefeuille-sur-Maine
GSK Investigational Site, Nantes
GSK Investigational Site, Canton
GSK Investigational Site, Cincinnati
GSK Investigational Site, Châlons-en-Champagne
GSK Investigational Site, Plymouth
GSK Investigational Site, Vannes
GSK Investigational Site, Metairie
GSK Investigational Site, Sunset
GSK Investigational Site, Oklahoma City
GSK Investigational Site, Corsicana
GSK Investigational Site, Colorado Springs
GSK Investigational Site, Villahermosa
GSK Investigational Site, Las Vegas
GSK Investigational Site, Long Beach
GSK Investigational Site, Newport Beach
GSK Investigational Site, Belgorod
GSK Investigational Site, Pyatigorsk
GSK Investigational Site, Kazan'
GSK Investigational Site, Penza
GSK Investigational Site, Novokuznetsk
GSK Investigational Site, Valparaíso
GSK Investigational Site, Santiago
GSK Investigational Site, Puente Alto - Santiago
GSK Investigational Site, Brick
GSK Investigational Site, Mendoza
GSK Investigational Site, Buenos Aires
GSK Investigational Site, Buenos Aires
GSK Investigational Site, Buenos Aires
GSK Investigational Site, Laon
GSK Investigational Site, Mexico City
Lead Sponsor
GlaxoSmithKline
INDUSTRY